Ticagrelor alone versus ticagrelor plus aspirin from month 1 to month 12 after percutaneous coronary intervention in patients with acute coronary syndromes (ULTIMATE-DAPT): a randomised, placebo-controlled, double-blind clinical trial
Nanjing Medical University · Punjab Institute of Cardiology · +17 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
147
total citations
- FWCI
- 54.82
- Percentile
- 100%
- References
- 31
Citations per year
Authors
63Topics & keywords
Topics
Keywords
- Medicine
- Ticagrelor
- Percutaneous coronary intervention
- Acute coronary syndrome
- Aspirin
- Myocardial infarction
- Internal medicine
- Clopidogrel
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.